Boston Scientific Corporation BSX · SEC Filings

59K

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing ...

Price44.02

Market Cap63.81 B

Float1.44 B

CountryUS

SectorHealthcare

ExchangeNYSE

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 2, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 3, 2026

11-K

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Jun 24, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 1, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 17, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 3, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Boston Scientific Announces Third Quarter 2026 Financial Results and Full Year Guidance

Oct 28, 2026

8-K

Boston Scientific Appoints Joseph M. Fitzgerald COO and Establishes New Operating Segments

Oct 7, 2026

8-K

Boston Scientific Announces Retirement of Executive Vice President Arthur C. Butcher

Sep 23, 2026

8-K

Boston Scientific Reports Cybersecurity Incident Update and Financial Guidance Impact

Sep 8, 2026

8-K

Boston Scientific Reports Global Cybersecurity Incident

Aug 26, 2026

8-K

Boston Scientific Announces Second Quarter 2026 Financial Results

Jul 29, 2026

Prospectus

TYPE

HEADLINE

FILED AT

425

Form 425 - Prospectuses and communications, business combinations

Apr 22, 2026

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Apr 1, 2026

425

Form 425 - Prospectuses and communications, business combinations

Mar 3, 2026

425

Form 425 - Prospectuses and communications, business combinations

Feb 4, 2026

425

Form 425 - Prospectuses and communications, business combinations

Jan 21, 2026

425

Form 425 - Prospectuses and communications, business combinations

Jan 20, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 8, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Mar 30, 2026

S-4

Form S-4 - Registration of securities, business combinations

Feb 27, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 21, 2025

S-3ASR

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 18, 2025

FWP

€2,000,000,000

Feb 22, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 18, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 18, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Mar 6, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 19, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 19, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2024

Ownerships

TYPE

HEADLINE

FILED AT

4

Mahoney Michael F (Reporting)

Nov 6, 2026

SCHEDULE 13G/A

BOSTON SCIENTIFIC CORP (Filed by)

Nov 6, 2026

4

O'Sullivan Miriam (Reporting)

Nov 3, 2026

4

O'Connor Padraig Andrew (Reporting)

Sep 3, 2026

4

Morano Susan E (Reporting)

Aug 26, 2026

4

Woodworth Emily (Reporting)

Aug 12, 2026

Other

TYPE

HEADLINE

FILED AT

SD

Form SD - Specialized disclosure report

May 21, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 2, 2026

CORRESP

Form CORRESP - Correspondence

Mar 30, 2026

LETTER

Form UPLOAD - SEC-generated letter

Mar 9, 2026

SD

Form SD - Specialized disclosure report

May 22, 2025

SD

Form SD - Specialized disclosure report

May 23, 2024